Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Gee

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Thrombosis Research|August 24, 2024
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? - A population pharmacokinetic analysisRachel E Clapham, Victoria Speed, Rosalind Byrne, et al.
BMJ Open Respiratory Research|August 21, 2020
British Thoracic Society Quality Standards for outpatient management of pulmonary embolismRobin Condliffe, Paul Albert, Raza Alikhan, et al.
Thrombosis Research|November 23, 2020
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemicRachna Patel, Julia Czuprynska, Lara N Roberts, et al.
Neurology International|January 25, 2022
Co-Designing a New Yoga-Based Mindfulness Intervention for Survivors of Stroke: A Formative EvaluationTharshanah Thayabaranathan, Maarten A Immink, Susan Hillier, et al.
Healthcare (Basel, Switzerland)|November 27, 2025
Movement-Based Mindfulness vs. Attention Control for Modifying Physiological Risk in Chronic Stroke: Evidence from a Feasibility TrialTharshanah Thayabaranathan, Marina Paul, Frederick R Walker, et al.
Disability and Rehabilitation|August 21, 2025
"<i>Rock on technology</i>": perspectives of people with neurological conditions on robot-assisted lower limb and gait neurorehabilitationRachel G Buckingham, Saran Chamberlain, Amanda Timler, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2020
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysisVictoria Speed, Bruce Green, Lara N Roberts, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Thrombosis Research|August 24, 2024
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? - A population pharmacokinetic analysisRachel E Clapham, Victoria Speed, Rosalind Byrne, et al.
BMJ Open Respiratory Research|August 21, 2020
British Thoracic Society Quality Standards for outpatient management of pulmonary embolismRobin Condliffe, Paul Albert, Raza Alikhan, et al.
Thrombosis Research|November 23, 2020
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemicRachna Patel, Julia Czuprynska, Lara N Roberts, et al.
Neurology International|January 25, 2022
Co-Designing a New Yoga-Based Mindfulness Intervention for Survivors of Stroke: A Formative EvaluationTharshanah Thayabaranathan, Maarten A Immink, Susan Hillier, et al.
Healthcare (Basel, Switzerland)|November 27, 2025
Movement-Based Mindfulness vs. Attention Control for Modifying Physiological Risk in Chronic Stroke: Evidence from a Feasibility TrialTharshanah Thayabaranathan, Marina Paul, Frederick R Walker, et al.
Disability and Rehabilitation|August 21, 2025
"<i>Rock on technology</i>": perspectives of people with neurological conditions on robot-assisted lower limb and gait neurorehabilitationRachel G Buckingham, Saran Chamberlain, Amanda Timler, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2020
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysisVictoria Speed, Bruce Green, Lara N Roberts, et al.
Pageof 2